APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,165,684 | -71.6% | 109,508 | -64.7% | 0.02% | -74.5% |
| Q4 2021 | $14,685,000 | -13.3% | 310,594 | -39.5% | 0.10% | -14.0% |
| Q3 2021 | $16,930,000 | +117.7% | 513,641 | +317.5% | 0.11% | +115.1% |
| Q2 2021 | $7,775,000 | -30.6% | 123,025 | -52.9% | 0.05% | -38.4% |
| Q1 2021 | $11,211,000 | +143.8% | 261,268 | +225.0% | 0.09% | +115.0% |
| Q4 2020 | $4,598,000 | +26.7% | 80,381 | -33.2% | 0.04% | +5.3% |
| Q3 2020 | $3,628,000 | +39.7% | 120,243 | +51.2% | 0.04% | +35.7% |
| Q2 2020 | $2,597,000 | – | 79,512 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |